Dynamic prognostic value of the revised international prognostic scoring system following pretransplant hypomethylating treatment in myelodysplastic syndrome-Reference-Cited by-同舟云学术

Dynamic prognostic value of the revised international prognostic scoring system following pretransplant hypomethylating treatment in myelodysplastic syndrome

Published:2016-11-28 Issue:4 Volume:52 Page:522-531
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Yahng S-A,Jeon Y-W,Yoon J-H,Shin S-H,Lee S-E,Choi Y-S,Kim D-Y,Lee J-H,Cho B-S,Eom K-S,Lee S,Min C-K,Kim H-J,Lee J-W,Lee K-H,Min W-S,Lee J-H,Kim Y-J

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2016295.pdf

Reference50 articles.

1. Corey SJ, Minden MD, Barber DL, Kantarjian H, Wang JC, Schimmer AD . Myelodysplastic syndromes: the complexity of stem-cell diseases. Nat Rev Cancer 2007; 7: 118–129.

2. Fenaux P, Mufti GJ, Hellstrom-Lindberg E, Santini V, Finelli C, Giagounidis A et al. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. Lancet Oncol 2009; 10: 223–232.

3. Kantarjian H, Issa JP, Rosenfeld CS, Bennett JM, Albitar M, DiPersio J et al. Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study. Cancer 2006; 106: 1794–1803.

4. Parmar S, de Lima M, Deeg HJ, Champlin R . Hematopoietic stem cell transplantation for myelodysplastic syndrome: a review. Semin Oncol 2011; 38: 693–704.

5. Yakoub-Agha I, Deeg J . Are hypomethylating agents replacing induction-type chemotherapy before allogeneic stem cell transplantation in patients with myelodysplastic syndrome? Biol Blood Marrow Transplant 2014; 20: 1885–1890.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms?;Blood;2024-07-25

2. Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysis;Blood;2022-09-22

3. Meta-analysis of the benefit of hypomethylating agents before allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes;Clinical and Experimental Medicine;2021-04-17

4. Differential effects of donor lymphocyte infusion upon treatment response and GVHD according to relapse level and donor sources in patients with myelodysplastic syndrome;Therapeutic Advances in Hematology;2021-01

5. Role of pretransplant anti‐thymocyte globulin in matched sibling donor stem cell transplantation after reduced intensity conditioning for myelodysplastic syndrome;European Journal of Haematology;2020-03-09